Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumabNathalie Chaput, Franck Carbonnel, L. Boselli et al.|Annals of Oncology|2017Cited by 1.3k
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combinationC. Boutros, Caroline Robert, Ahmad A. Tarhini et al.|Nature Reviews Clinical Oncology|2016Cited by 1.1k
Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survivalJulie Delyon, Caroline Robert, Céu Mateus et al.|Annals of Oncology|2013Cited by 314